Following numerous public consultations and town hall meetings, the draft Grenada National Disability Policy and Strategic Action Plan is near completion

View the full post Grenada National Disability Policy being finalised on NOW Grenada.

Dr Floyd Morris: I strongly believe that without inclusion, there should be no vote, and without empowerment, there should be no vote

View the full post No inclusion, no vote on NOW Grenada.

One Communications, in partnership with the Ministry of Health and several non-governmental organisations, collectively referred to as Champions of Hope, officially launched Pinktober 2024 on Friday, continuing its mission to raise awareness and support for cancer fighters and survivors across Guyana, the company said. Speaking at the launch event themed ‘Many Hearts, One Fight,’ Ian ...

View the full post Procurement and pension legislations for approval in 2024/2025 parliamentary year on NOW Grenada.

“The challenges before us are many, but so are the opportunities to build a future that is more just, prosperous, and inclusive”

View the full post Throne Speech 2024: Unifying our Focus Toward Vision 75 on NOW Grenada.

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. 

Good morning. Today, we look at the biggest biotech events to watch this quarter. And as my editor had to remind me (since I’m still in denial), we are indeed in the fourth quarter now.

Read the rest…

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. 

Good morning. It’s another busy news day, and I’m layering up at home to avoid turning the heater on. Fall is officially here.

Read the rest…

Good morning. If you’re following the European Society for Medical Oncology meeting that starts tomorrow, sign up for our ESMO in 30 Seconds newsletter. My colleague Drew Joseph is on the ground in Barcelona (and I’m very jealous of him).

Onto the biotech news of the day.

Read the rest…

On Sunday, a small biotech company called Summit Therapeutics won a remarkable victory, saying its experimental drug outperformed Merck’s Keytruda, the world’s best-selling drug, in non-small cell lung cancer, the disease that represents Keytruda’s biggest market.

By itself, Summit’s victory would be a dramatic story, although not an unheard of one in the unpredictable world of biotechnology. But it’s just the start. Because at the center of it is one of the industry’s most iconoclastic figures: Robert “Bob” Duggan, who became a billionaire after he bought up shares of another biotech company, Pharmacyclics, that was on the brink of failure, developed a breakthrough cancer drug, and sold the company to AbbVie for $21 billion.

Duggan, 80, is a living rebuke to a pharmaceutical industry self-image that is increasingly crafted in Cambridge, Mass. and San Francisco. Before Pharmacyclics, he had no drug industry experience, having worked in cookie stores and then surgical robots. He lacks a college degree, and is a practicing scientologist who told STAT in an interview that he reads the works of Scientology founder L. Ron Hubbard every day and who has in the past said he’d given the church more than $360 million. He speaks in long, dramatic arcs, often spelling out words, referencing their roots, or giving itemized lists.

Continue to STAT+ to read the full story…

Guyana continues to take numerous steps to convince the United States Department of Agriculture (USDA) that the now six-year-old ban on catfish exports should be lifted, officials said Wednesday. Chief Fisheries Officer of the Ministry of Agriculture, Denzil Roberts said Guyana’s relevant fisheries regulations and inspection manuals have been updated. US Ambassador to Guyana, Nicole ...